BPH Global Registry
Recruiting now
Conditions studied: Benign Prostatic Hyperplasia, Lower Urinary Tract Symptoms
In brief
Benign prostatic hyperplasia (BPH) is one of the most common performed surgical procedures in urology. Over the past few decades there have been an increasing development of newer surgical treatment options. Additionally, the outcome parameters for BPH treatments have been standardized. While data are available for the initial pivotal studies, post-market release data are lacking. Under the umbrella of uCARE, we have started a prospective, ongoing international registry for recording demographics and outcomes for patients undergoing surgical treatments for BPH.
Key facts
- Study ID
- NCT05543200
- Run by
- Société Internationale d'Urologie
- People needed
- 7500
- Starts
- 2023-03-13
- Expected to finish
- 2027-03-01
- Last updated by the study team
- 2026-04-24
Who can join
Age: 18 and older. Sex: male. Healthy volunteers: not accepted.
You may qualify if…
- Primary diagnosis of BPH with LUTS with prescribed medical treatment or surgical intervention
You may not qualify if…
- Non-symptomatic BPH
- No treatment prescribed for BPH
Where it is running
- Southend University Hospital — Southend-on-Sea, United Kingdom (enrolling)
- Toronto Western Hospital, University Health Network — Toronto, Ontario, Canada (enrolling)
- McGill University Health Centre — Montreal, Quebec, Canada (enrolling)
- Institute of Kidney Diseases Peshawar — Peshawar, Pakistan (enrolling)
- Lady Reading Hospital — Peshawar, Pakistan (enrolling)
- Hamad Medical Corporation Qatar — Doha, Qatar (enrolling)
- Istanbul Medipol University — Istanbul, Turkey (Türkiye) (enrolling)
- Keck Medicine of USC — Los Angeles, California, United States (enrolling)
- Hospital Dr. Juan Morey La Unión — La Unión, Chile (enrolling)
- Hospital del Trabajador — Santiago, Chile (enrolling)
- The First Affiliated Hospital, Zhejiang University School of Medicine — Hangzhou, China (enrolling)
- Shariati Hospital — Tehran, Iran (enrolling)
- University of Basrah — Basra, Iraq (enrolling)
- Azienda Ospedaliero-Universitaria Careggi — Florence, Italy (enrolling)
- Sapienza University of Rome, Division of Urology, Ospedale Sant'Andrea — Rome, Italy (enrolling)
- American University of Beirut — Beirut, Lebanon (enrolling)
- Universiti Malaya — Kuala Lumpur, Malaysia (enrolling)
- Kati University Hospital — Kati, Mali (enrolling)
- Centro Medico Nacional Siglo XXI — Mexico City, Mexico (enrolling)
- Benue State University Teaching Hospital, Department of Surgery — Makurdi, Nigeria (enrolling)
- Ahmadu Bello University Teaching Hospital — Zaria, Nigeria (enrolling)
- University of Montreal Hospital Center — Montreal, Canada
- The Chinese University of Hong Kong — Hong Kong, Hong Kong
- Imperial College Healthcare NHS Trust — London, United Kingdom
- Seoul National University Bundang Hospital — Seongnam, South Korea
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.